Lung hyperinflation in COPD: the impact of pharmacotherapy
Improvement in airway function in response to bronchodilator therapy is generally confirmed by simple spirometry. However, improvements in maximal expiratory flow rates have been shown to correlate poorly with important patient-centred outcomes, such as reduced exertional dyspnoea and improved exerc...
Main Authors: | D. E. O'Donnell, P. Laveneziana |
---|---|
Format: | Article |
Language: | English |
Published: |
European Respiratory Society
2006-12-01
|
Series: | European Respiratory Review |
Subjects: | |
Online Access: | http://err.ersjournals.com/cgi/content/full/15/100/85 |
Similar Items
-
Physiology and consequences of lung hyperinflation in COPD
by: D. E. O'Donnell, et al.
Published: (2006-12-01) -
Impacting patient-centred outcomes in COPD: breathlessness and exercise tolerance
by: D. E. O'Donnell
Published: (2006-12-01) -
Relationship between exercise endurance and static hyperinflation in a post hoc analysis of two clinical trials in patients with COPD
by: Singh S, et al.
Published: (2018-01-01) -
Exercise and dyspnoea in COPD
by: P. M. A. Calverley
Published: (2006-12-01) -
Dynamic hyperinflation and pulmonary inflammation: a potentially relevant relationship?
by: A. Agusti, et al.
Published: (2006-12-01)